BR100 Increased By (0.72%)
BR30 Increased By (1.31%)
KSE100 Increased By (0.9%)
KSE30 Increased By (1.08%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.38 Increased By ▲ 0.15 (0.48%)
CNERGY 11.72 Increased By ▲ 0.13 (1.12%)
CSIL 5.93 Increased By ▲ 0.21 (3.67%)
FCCL 61.14 Decreased By ▼ -0.40 (-0.65%)
FFL 14.85 Decreased By ▼ -0.17 (-1.13%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.25 Decreased By ▼ -0.01 (-0.16%)
KOSM 6.07 Increased By ▲ 0.51 (9.17%)
LOTCHEM 24.90 Increased By ▲ 0.22 (0.89%)
MLCF 104.16 Increased By ▲ 0.08 (0.08%)
NBP 174.49 Decreased By ▼ -0.79 (-0.45%)
NCPL 52.99 Increased By ▲ 0.22 (0.42%)
NPL 54.49 Increased By ▲ 0.37 (0.68%)
OGDC 319.89 Increased By ▲ 6.50 (2.07%)
PACE 9.48 Increased By ▲ 0.28 (3.04%)
PAEL 35.78 Decreased By ▼ -0.02 (-0.06%)
PIBTL 13.89 Increased By ▲ 0.42 (3.12%)
PPL 229.80 Increased By ▲ 7.99 (3.6%)
PRL 80.60 Increased By ▲ 1.52 (1.92%)
PTC 47.00 Increased By ▲ 0.15 (0.32%)
SSGC 24.10 Increased By ▲ 0.23 (0.96%)
TBL 9.37 Increased By ▲ 0.06 (0.64%)
TELE 7.70 Increased By ▲ 0.31 (4.19%)
TPL 24.85 Decreased By ▼ -0.26 (-1.04%)
TPLP 12.89 Increased By ▲ 0.38 (3.04%)
TREET 26.15 Decreased By ▼ -0.10 (-0.38%)
TRG 53.80 Increased By ▲ 0.36 (0.67%)
World

Key facets of the $900 billion U.S coronavirus relief bill

  • On Sunday, bipartisan lawmakers in the United States Congress released a long-awaited $900 billion coronavirus relief bill, which is expected to be signed into law by President Trump.
  • This relief package will be combined with an additional $1.4 trillion in federal funding and tax provisions to facilitate federal agencies through the end of September.
Published Updated

On Sunday, bipartisan lawmakers in the United States Congress released a long-awaited $900 billion coronavirus relief bill, which is expected to be signed into law by President Trump.

This relief package will be combined with an additional $1.4 trillion in federal funding and tax provisions to facilitate federal agencies through the end of September.

Democrats have argued that more relief legislation will be required once President-elect Biden takes office in January, which would include local provisions at the state level; as the United States Congress will have appropriated nearly $4 trillion in federal funding to respond to the coronavirus pandemic, which has claimed the lives of over 300,000 people across the country.

The key facets of this $900 billion relief package are as follows:

  • Stimulus Checks: This bill includes a second-round of direct payments to Americans, with up to $600 for every adult and child. It can be observed that this is half the $1200 disbursements under the CARES Act in March.
  • Unemployment Benefits: This bill will renew two expiring CARES Act programs for an additional 11 weeks, namely the Pandemic Unemployment Assistance which made benefits available to self-employed workers, and the Pandemic Emergency Unemployment Compensation which provided additional weeks of benefits. Furthermore, this bill will include an additional $300 to all weekly unemployment benefits and an additional $100 weekly for those who rely on multiple jobs.
  • Support for Small Businesses: The Paycheck Protection Program, which provided distressed small businesses with forgivable loans to keep them afloat, was granted an additional $284 billion in funds.
  • Housing Assistance: The bill extends the eviction moratorium that is set to expire at the end of the year through the end of January, including $25 billion for rental assistance to families facing eviction.
  • Education: The bill includes several provisions pertaining to elementary, secondary and higher education; providing $82 billion worth of funds for schools and colleges to help them reopen classrooms and prevent virus transmission.
  • Testing: The bill includes $20 billion for the purchase of vaccines, $8 billion for vaccine distribution, $20 billion for states to conduct testing and an additional $20 billion in federal relief for health-care providers.

Comments

Comments are closed for this article.